The interplay of YKL-40 and leptin in type 2 diabetic obese patients

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages

  El Mesallamy, Hala O ^a   Mostafa, Ahmed M ^a   Amin, Ashraf I ^b   El Demerdash, Ebtehal ^a  

^a Ain Shams University   (Egypt)

^b National Institute of Diabetes and Endocrinology (NIDE)   (Egypt)

Author keywords

Inflammatory marker; Low grade inflammation; Obesity

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; LEPTIN; UNCLASSIFIED DRUG; YKL 40;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE;

ADIPOKINES; ADULT; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; LECTINS; LEPTIN; MALE; MIDDLE AGED; OBESITY;

EID: 80052741548     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.040     Document Type: Article

References (16)

1. Houston D.R., Recklies A.D., Krupa J.C., van Aalten D.M. Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol Chem 2003, 278(32):30206-30212.
2. Rathcke C.N., Johansen J.S., Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006, 55(2):53-59.
3. Ruhl C.E., Harris T.B., Ding J., Goodpaster B.H., Kanaya A.M., Kritchevsky S.B., et al. Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clin Nutr 2007, 85(4):1121-1126.
4. Brennan A.M., Mantzoros C.S. Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006, 2(6):318-327.
5. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
6. Nielsen A.R., Erikstrup C., Johansen J.S., Fischer C.P., Plomgaard P., Krogh-Madsen R., et al. Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 2008, 57(11):3078-3082.
7. Rathcke C.N., Persson F., Tarnow L., Rossing P., Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009, 32(2):323-328.
8. Cintin C., Johansen J.S., Christensen I.J., Price P.A., Sorensen S., Nielsen H.J. Serum YKL-40 and colorectal cancer. Br J Cancer 1999, 79(9-10):1494-1499.
9. Hinoi E., Gao N., Jung D.Y., Yadav V., Yoshizawa T., Myers M.G., et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 2008, 183(7):1235-1242.
10. Hinoi E., Gao N., Jung D.Y., Yadav V., Yoshizawa T., Kajimura D., et al. An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann N Y Acad Sci 2009, 1173(Suppl1):E20-30.
11. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34(1):2-11.
12. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996, 81(9):3424-3427.
13. Hellstrom L., Wahrenberg H., Hruska K., Reynisdottir S., Arner P. Mechanisms behind gender differences in circulating leptin levels. J Intern Med 2000, 247(4):457-462.
14. Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008, 14(12):1225-1230.
15. Maachi M., Pieroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF[alpha], leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004, 28(8):993-997.
16. Rathcke C.N., Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009, 8:61.